Varki et al. observed that 26% of the investigated cSCC patients in their study had PD-L1-expressing tumors [102], and 20% of high-risk cSCC and 41% of metastatic cSCC evaluated by Slater and Googe had PD-L1-positive tumor cells [103]. This evidence concerns the gene CD274 and skin squamous cell carcinoma.